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ABTRACT  
Objectives 
Delirium is common and distressing in palliative care settings. This survey aims to describe 
current practice regarding delirium identification in specialist palliative care units (SPCUs), 
such as inpatient hospices, in the UK.  
Methods 
An 18-item anonymous online survey was distributed by Hospice UK to their network of 
clinical leads (n=223), and to their research mailing list (n=228). The survey was also sent to 
the chair of the Hospice UK executive clinical leads forum for direct dissemination to forum 
representatives (n=20). Clinical leads and forum representatives were asked to distribute the 
survey to healthcare staff in their SPCUs.  
Results 
220 SPCU staff (48% nurses; 31% doctors; 10% healthcare assistants) completed the survey. 
Approximately half reported using clinical judgement alone to screen (97/204; 48%) and/or 
diagnose (124/220;56%) delirium. Over a third used an assessment tool to screen for delirium 
(78/204;38%). The majority (150/220;68%) reported screening in response to clinical 
symptoms, while few reported routine on-admission (11/220;5%) or daily-during admission 
(12/220;6%) screening. Most respondents had received some training on delirium (137/220; 
62%). However, 130/220 (59%) said their SPCU did not have a training program for delirium 
screening and only 79/220 (36%) reported that their SPCU had delirium clinical guidelines. 
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The main barriers to routine screening included: lack of delirium training, lack of guidelines 
and complexity of patient’s conditions.  
Conclusion 
There is variation in practice for delirium screening and diagnosis in SPCUs. Clinical 
guidelines for delirium, including consensus on which screening tools to use, are needed for 
this setting.  
 




Delirium is a fluctuating, acute confusional state.[1] Patients in specialist palliative care units 
(SPCUs) are at increased risk of delirium.[2] Approximately one third of patients have 
delirium on admission and 58-88% in the weeks or days preceding death.[2] 
Delirium is distressing for the patient, their family, friends and healthcare staff,[3] and 
reduces patients’ ability to communicate.[4] Fluctuating symptoms need regular, systematic 
assessment of delirium,[5] which is rarely implemented. Sub-optimal identification and 
management persists.[6] 
Delirium can be screened for and, if indicated, confirmed by diagnostic assessment. 
Screening tools are available, but most are untested in this setting, and no consensus exists 
for SPCUs.[7] Diagnostic assessments, such as a clinical interview, follow standardised 
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criteria, for example the Diagnostic Statistical Manual of Mental Disorders, fifth edition 
(DSM-5).  
Little is known about how delirium is identified in SPCUs, although a recent survey of UK 
palliative physicians reported that 59% never use a screening tool.[8] We aimed to gain 
insight into multi-disciplinary practice for identifying delirium in SPCUs, in the UK.  
 
METHODS 
Design and sample 
We surveyed a convenience sample of SPCU healthcare staff and managers. Hospice UK, a 
national hospice charity, invited their network of clinical leads at registered SPCUs (n=223), 
to email the survey to their healthcare staff. Hospice UK also sent the survey directly to staff 
on their Research and Outcomes mailing list (n=228) and to the chair of the Hospice UK 
executive clinical leads forum for direct dissemination to forum representatives (n=20).  
Survey development 
An online 18-item survey was designed to collect quantitative and qualitative data, managed 
on the software platform, Qualtrics. The survey was informed by current literature and 
researcher expertise and was pilot-tested with delirium and palliative care specialists, patients 






The invitation email explained the purpose of the study and provided the survey URL 
(available 5​th​ July-20​th​ August 2019). Survey data were anonymous, and completion and 
submission was taken as implied consent; only fully completed surveys were used. 
Institutional ethics approval was obtained prior to data collection. 
Analysis 
Data were exported from Qualtrics to Excel and the Statistical Package for the Social 
Sciences (IMB-SPSS Statistics 25) to prepare descriptive statistics. Free text was analysed 
using thematic analysis.  
 
RESULTS 
220 SPCU staff (90% female; 31% doctors; 48% nurses; 10% healthcare assistants) 
submitted completed surveys. All health care regions in England were represented. Most 
responses were from England (88%) with some from Wales (6%), Scotland (3%) and 
Northern Ireland (2%). Although wide delivery of the survey was achieved, the number of 
potential respondents was unknown due to the distribution methods (supplementary table 1). 
Screening for delirium  
Just over two-thirds (150/220;68%) reported only screening in response to clinical symptoms 
of delirium. Few reported routine on-admission (11/220;5%) or daily-during-admission 
(12/220;6%) screening (table 1). Respondents reported doctors (n=167), nurses (n=122) and 
healthcare assistants (n=30) undertook screening in their SPCUs (supplementary table 2).  
The tools and methods used to screen varied. Most commonly (97/204, 48%), clinical 
judgement alone was used. A few, (20/204; 10%) used the 4‘A’s test (4AT),[9] and 
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13/204(6%) used the Confusion Assessment Method (CAM); mostly the short CAM.[10]. 
Overall, over a third (78/204;38%) reported using an assessment tool to screen for delirium, 
either on its own, mostly 4AT or CAM (50/204; 24.5%) or alongside clinical judgement 
(28/204; 13.7%). Thirty-one (15%) reported they did not screen (table 1). Some reported 
following hospice guidelines as the main reason for using a particular tool (n=74) 
(supplementary table 3).  
Diagnosing delirium 
Just over half, 124/220(56%) used clinical judgement to diagnose delirium following a 
positive screen, but very few used a standard method (1% DSM-V; 1% ICD-10/ICD-11). 
Thirteen (6%) reported no further assessment was undertaken (table 1).  
 
Table 1:  
Screening and diagnosing delirium survey responses n (%) 
Q1: How often do you screen 
patients for delirium? n=220 
Never 19 (8.6) 
On admission 11 (5) 
Daily (or more than once a day) 12 (5.5) 
Most days 4 (1.8) 
Weekly 2 (0.9) 
As required (when symptoms of 
delirium present) 
150 (68.2) 
Not applicable – I don’t have a 
clinical role 
16 (7.3) 
Other (please specify) 6 (2.7) 
Q2: ​Which assessment tool(s) 
or methods, if any, do you use 
to screen for delirium? 
n=204* 
Clinical Judgement (alone) 
- and 4AT 
- and CAM 
- and AMT4 
- and DOS 
97 (47.5) 
- 15 (7.4) 
- 10 (4.9) 
- 2 (0.9) 
- 1 (0.5) 
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- total using an assessment tool 
alongside clinical judgement 
- 28 (13.7) 
CAM 13 (6.4) 
4AT 20 (9.8) 
SQiD 1 (0.5) 
DOS 2 (1) 
Nu-DESC 0 (0) 
NEECHAM 0 (0) 
More than one tool used 5 (2.5) 
Other 9 (4.4) 
Total reporting using an assessment 
tool on its own 
50 (25) 
Not applicable – I do not screen for 
delirium** 
31 (15.2) 
Q3: When a patient screens 
positive for delirium, is the 
delirium diagnosis confirmed 
with a further assessment? 
n=220 
 
Clinical judgement 124 (56.4) 
DSM-V 1 (0.5) 
ICD-10 1 (0.5) 
Clinical judgement and DSM-V 2 (0.9) 
Clinical judgement and ICD-11 1 (0.5) 
Clinical judgement and basic 
observations 
1 (0.5) 
Clinical judgement and Mental 
health nurse review 
1 (0.5) 
Clinical Judgement and Medical 
team review 
1 (0.5) 
Other tool 3 (1.4) 
Other 9 (4.1) 
Not applicable - do not screen for 
delirium** 
51 (23.2) 
Not applicable – I do not have a 
clinical role** 
12 (5.5) 
No further assessment** 13 (5.9) 
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* Those who answered ‘N/A – I don’t have a clinical role’ to the previous question, were not 
asked this question. 
** Exclusive answer – no other answer could be selected alongside. Other answers are 
‘select all that apply’.  
 
Training and guidelines for delirium 
Of the 220 respondents, 137/220(62%) had received some delirium training, 44/220(20%) 
reported their SPCU had a training programme about screening for delirium, and 
79/220(36%) reported their SPCU had delirium guidelines (supplementary table 4). 
Barriers and facilitators to delirium screening 
The main barriers to routine delirium screening identified were: clinical complexity (n=107); 
lack of training (n=89), and lack of guidance (n=76)(supplementary table 5). The complex 
presentations, and communication difficulties, of some patients with advanced illness, were 
perceived as barriers: 
 “…if someone has confusion in hospice it can be so many variables, disease progression and 
medication. Very difficult I think.” (Pt 149, nurse) 
“…many of our patients are not well enough to communicate on admission so it would not be 
possible to screen all patients” (Pt 203, doctor) 
Staff identified burden of existing paperwork as a significant barrier, 
“…Whatever the benefit of an individual tool it is the overwhelming nature of all information 
that must now be gathered and entered onto I.T systems that I believe is the main 
barrier.”(Pt 147, doctor) 
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An important facilitator was increased education and training about delirium, its 
identification, the use of screening tools and their benefits,  
“​How screening for this may make a conceivable difference​” ​(Pt 40, doctor) 
Use of a screening tool was seen as useful but needed to be:  
● Quick and easy to use, ​“Simple tool that all could feel empowered to use” (Pt 15, 
doctor) 
● Suitable for palliative care, (“​specific to palliative care and hospice settings​” ​(Pt 78, 
doctor) 
● A valued and established part of the process of clinical care: 
“​Seen as an important factor” (Pt 41, nurse) 
“Embedded in practice” (Pt 197, doctor) 
“Clear process for what to do post screening to make a difference.” (Pt 15, doctor) 
Clear delirium guidelines, appropriate for palliative care, were also felt to be needed. 
“Specific guidelines to adhere to by all levels of staff involved in patient care (Pt 59, nurse)”. 
“Some clear guidance supported by Hospice UK or other research body” (Pt 195, nurse) 
DISCUSSION 
This survey provides insight into delirium screening practice by SPCU staff, in the UK. Most 
used clinical judgement in response to clinical signs and symptoms to screen for delirium. A 
minority (38%) used a screening tool, and even fewer screened routinely. Few diagnosed 
delirium against standard clinical criteria. A lack of training and use of clinical delirium 
guidelines was apparent, consistent with results of the UK palliative care physicians 
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survey[8]; practice is similar across disciplines, although healthcare assistants reported 
screening the least, reporting they had no role in this aspect of clinical care. 
 
The most striking finding is that most clinicians only screened in response to overt clinical 
suspicion. Clinical judgement alone misses over half (61%) of delirium cases.[11] Failing to 
detect delirium until symptoms are clearly apparent may miss opportunities to reverse causes 
in those with a narrow window of opportunity, or to manage the delirium without recourse to 
sedation.[6] Dependence on clinical expertise also depends on staff experience, an issue with 
variable clinical training and use of guidelines. It is important to note that the survey assumed 
an understanding of ‘screening’. Misinterpretation of this term could have affected how staff 
answered the questions, potentially misinterpreting screening for diagnosis.  
 
The low use of guidelines, or clinical training, may be influenced by the stated exclusion of 
end-of-life and palliative care in the National Institute for Clinical Excellence guideline on 
delirium for England and Wales,[12]; perhaps then interpreted as irrelevant. However, the 
guideline specifically signposts to the related NICE guideline for care of adults in the last 
days of life which includes consistent general guidance for delirium.[13] The recently 
published Scottish SIGN delirium guidelines explicitly ​include​ palliative care settings and 
recommend the use of the 4AT.[14] 
Screening was perceived as burdensome for the patient and clinical complexity made it 
difficult to screen; consistent with Australian data.[15] Increasing training and use of 
delirium guidelines may address these barriers.  
Strengths and limitations 
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Responses were received from all healthcare regions in England, all UK nations and from 
different job roles. However, as the denominator was unknown, we cannot draw further 
conclusions about representativeness. To preserve anonymity, we did not identify individual 
SPCUs. Therefore, the number represented is unknown. In addition, although most 
respondents are likely to be hospice staff, we used the term SPCU to be inclusive of staff who 
may have responded from other palliative care settings. Due to the distribution methods of 
the survey (via Hospice UK) we do not know if these findings are representative of other 
palliative care settings (for example, community palliative care). 
A further limitation, inherent with this study design; we know nothing about those who chose 
not to participate, who may hold different views or have different practices. However, its 
likely those with an interest and knowledge in delirium would have participated, and that we 
have not ​under​-estimated good practice.  
Implications for clinical practice and research 
Our data indicate patients with delirium are at risk of being missed and potentially 
sub-optimally managed. Systematic implementation of NICE and SIGN guidance for 
screening and management may increase the chance of early detection and management. 
Future research should gain consensus regarding a SPCU screening tool, guidelines and 
training, and identify the best ways to implement good delirium care in clinical practice. 
CONCLUSION 
A small minority of clinicians routinely screen for delirium in SPCUs. Agreed tools, 
guidelines and clinical training for the palliative care setting would be useful to help 







Ethical approval was obtained from the University of York, Health Sciences Research 
Governance Committee on 13​th​ May 2019, ref HSRGC/2019/336/F.  
Acknowledgements 
The authors would like to thank Hospice UK for their valuable help and to everyone who 
completed the survey. Thank you also to our delirium and palliative care patient and public 
involvement panel for their valuable contribution this project.  
Competing Interests 
None declared.  
Funding 
No external funding was received to conduct this research project. 
RW is supported by a research fellowship from Hull York Medical School. 
Licence for Publication 
The Corresponding Author has the right to grant on behalf of all authors and does grant on 
behalf of all authors, an exclusive licence (or non exclusive for government employees) on a 
worldwide basis to the BMJ Publishing Group Ltd to permit this article (if accepted) to be 
published in BMJ Supportive and Palliative Care and any other BMJPGL products and 








1 Inouye S, Westendorp R, & Saczynski J. Delirium in elderly people. ​Lancet, 
2014;383(9920):911–22. doi.org/10.1016/S0140-6736(13)60688-1 
2 Watt C, Momoli F, Ansari M, et al. The incidence and prevalence of delirium across 
palliative care settings: A systematic review. ​Palliative Medicine ​2019;33(8):1-13. 
doi.org/10.1177/0269216319854944 
3 Bruera E, Bush SH, Willey J, et al. Impact of delirium and recall on the level of 
distress in patients with advanced cancer and their family caregivers. ​Cancer​, 
2009;115:2004–12. doi.org/10.1002/cncr.24215 
4 Finucane A, Lugton J, Kennedy C, et al. The experiences of caregivers of patients 
with delirium, and their role in its management in palliative care settings: an 
integrative literature review. ​Psycho-Oncology ​2017;26:291-300. 
doi.org/10.1002/pon.4140 
5 Delgado-Guay MO, Yennurajalingam S, Bruera E. Delirium with severe symptom 
expression related to hypercalcemia in a patient with advanced cancer: an 
interdisciplinary approach to treatment. ​J Pain Symptom Manag​ 2008;36(4):442–44. 
doi.org/10.1016/j.jpainsymman.2007.11.004 
6 Fang CK, Chen HW, Lui SI, et al. Prevalence, Detection and Treatment of Delirium 
in Terminal Cancer Inpatients: A Prospective Survey.​ Japanese Journal of Clinical 
Oncology ​2008; 38(1):56-63. doi.org/10.1093/jjco/hym155 
14 
 
7 De J, & Wand A. Delirium Screening: A Systematic Review of Delirium Screening 
Tools in Hospitalized Patients. ​The Gerontologist, ​2015;55(6): 1079-99. 
doi.org/10.1093/geront/gnv100 
8 Boland JW, Kabir M, Bush SH, et al. Delirium management by palliative medicine 
specialists: a survey from the association for palliative medicine of Great Britain and 
Ireland. ​BMJ Supportive & Palliative Care​ 2019;0:1-8. 
doi.org/10.1136/bmjspcare-2018-001586 
9 MacLullich A. The 4 "A"s Test. Available from: ​www.the4AT.com​. Accessed 
October 2019 
10 Inouye SK, van Dyck CH, Alessi CA, et al.. Clarifying confusion: the confusion 
assessment method. A new method for detection of delirium. ​Ann Intern Med 
1990;113:941–8. doi.org/10.7326/0003-4819-113-12-941 
11 de la Cruz M, Fan J, Yennu S, et al. The frequency of missed delirium in patients 
referred to palliative care in a comprehensive cancer center. ​Support Care Cancer 
2015;23:2427–33. doi.org/10.1007/s00520-015-2610-3 
12 National Institute for Health and Care Excellence. Delirium: prevention, diagnosis 
and management. ​NICE guideline 103 ​2010. Available from 
https://www.nice.org.uk/guidance/CG103? UNLID=71857637201581742332. 
Accessed October 2019 
13 National Institute for Health and Care Excellence (NICE). Care of dying in the last 
days of life. NICE guideline. Published 16 December 2015. Available from: 
https://www.nice.org.uk/guidance/ng31. Accessed October 2019 
15 
 
14 Scottish Intercollegiate Guidelines Network (SIGN). Risk reduction and management 
of delirium. Edinburgh: SIGN; 2019. (SIGN publication no. 157). [March 2019]. 
Available from URL: http://www.sign.ac.uk 
15 Hosie A, Lobb E, Agar M et al. Identifying the Barriers and Enablers to Palliative 
Care Nurses' Recognition and Assessment of Delirium Symptoms: A Qualitative 
Study. ​Journal of Pain and Symptom Management​, 2014;48(5), 815-830. 
doi.org/10.1016/j.jpainsymman.2014.01.008 
 
16 
 
